Aethlon Medical, Inc. SEC filings AEMD

Aethlon Medical, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Feb 14, 2003. Its latest annual report, Form 10-K, was filed on Jun 10, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (bylaw or fiscal year change). The company's fiscal year ends on March 31.

Aethlon Medical, Inc. SEC filings
Form Description Filed Period
8-K Current report
Bylaw or fiscal year change
Oct 9, 2026 Oct 7, 2026
8-K/A Amended current report
Shareholder vote results
Oct 5, 2026 Oct 1, 2026
8-K Current report
Officer or director change, Shareholder vote results
Oct 1, 2026 Oct 1, 2026
425 Form 8-k Sep 17, 2026 —
8-K Current report
Material agreement, Change in control, Regulation FD disclosure
Sep 17, 2026 Sep 17, 2026
8-K Current report
Officer or director change
Sep 15, 2026 Sep 11, 2026
DEFA14A Additional proxy material Sep 4, 2026 —
DEF 14A Proxy statement Sep 1, 2026 Oct 1, 2026
8-K Current report
Other events
Aug 31, 2026 Aug 28, 2026
PRE 14A Preliminary proxy statement Aug 21, 2026 Oct 1, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2026 Aug 13, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jul 31, 2026 Jul 30, 2026
8-K Current report
Material agreement, Other events
Jul 8, 2026 Jul 6, 2026
424B3 Prospectus Jul 7, 2026 —
EFFECT Filing Jul 6, 2026 —
S-1/A Amended registration statement Jul 1, 2026 —
S-1/A Amended registration statement Jul 1, 2026 —
S-1 Registration statement Jun 22, 2026 —
S-8 Employee stock plan registration Jun 10, 2026 —
10-K Annual report Jun 10, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jun 10, 2026 Jun 10, 2026
8-K Current report
Other events
Jun 4, 2026 Jun 4, 2026
424B5 Prospectus supplement Jun 4, 2026 —
DRS Filing May 5, 2026 —
8-K Current report
Other events
Mar 17, 2026 Mar 16, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Feb 23, 2026 Feb 19, 2026
10-Q Quarterly report Feb 12, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 12, 2026 Feb 12, 2026
424B3 Prospectus Jan 27, 2026 —
DEFA14A Additional proxy material Jan 27, 2026 —
8-K Current report
Material agreement
Jan 26, 2026 Jan 22, 2026
EFFECT Filing Jan 16, 2026 —
424B3 Prospectus Jan 16, 2026 —
DEF 14A Proxy statement Jan 16, 2026 Feb 19, 2026
CORRESP Letter to the SEC Jan 14, 2026 —
UPLOAD Letter from the SEC Jan 13, 2026 —
S-1 Registration statement Jan 7, 2026 —
EFFECT Filing Jan 2, 2026 —
CORRESP Letter to the SEC Dec 30, 2025 —
UPLOAD Letter from the SEC Dec 30, 2025 —
S-3 Shelf registration Dec 23, 2025 —
D Filing Dec 23, 2025 —
8-K Current report
Material agreement, Change to shareholder rights, Regulation FD disclosure
Dec 8, 2025 Dec 2, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 12, 2025 Nov 12, 2025
8-K Current report
Other events
Nov 6, 2025 Nov 6, 2025
8-K Current report
Listing notice
Oct 22, 2025 Oct 22, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Oct 16, 2025 Oct 16, 2025
8-K Current report
Other events
Sep 12, 2025 Sep 12, 2025
8-K Current report
Material agreement, Other events
Sep 9, 2025 Sep 4, 2025
424B4 Prospectus Sep 5, 2025 —
EFFECT Filing Sep 4, 2025 —
CORRESP Letter to the SEC Aug 29, 2025 —
CORRESP Letter to the SEC Aug 29, 2025 —
S-1/A Amended registration statement Aug 29, 2025 —
8-K Current report
Regulation FD disclosure
Aug 21, 2025 Aug 21, 2025
S-1 Registration statement Aug 20, 2025 —
1-A-W Form rw Aug 20, 2025 —
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2025 Aug 13, 2025
UPLOAD Letter from the SEC Jul 29, 2025 —
DRS Filing Jul 25, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Jun 27, 2025 Jun 26, 2025
10-K Annual report Jun 26, 2025 Mar 31, 2025
8-K Current report
Other events
Jun 5, 2025 Jun 5, 2025
8-K Current report
Shareholder vote results
May 13, 2025 May 13, 2025
DEF 14A Proxy statement Apr 18, 2025 May 13, 2025
PRE 14A Preliminary proxy statement Apr 8, 2025 May 13, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights
Mar 17, 2025 Mar 16, 2025
10-Q Quarterly report Feb 12, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 12, 2025 Feb 12, 2025
1-A/A Filing Jan 30, 2025 —
8-K Current report
Listing notice
Jan 8, 2025 Jan 7, 2025
1-A Filing Dec 27, 2024 —
8-K Current report
Other events
Dec 20, 2024 Dec 20, 2024
S-8 Employee stock plan registration Nov 15, 2024 —
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2024 Nov 13, 2024
8-K Current report
Other events
Nov 12, 2024 Nov 11, 2024
8-K Current report
Officer or director change
Oct 3, 2024 Oct 3, 2024
8-K Current report
Officer or director change, Shareholder vote results
Oct 2, 2024 Sep 27, 2024
8-K Current report
Other events
Sep 19, 2024 Sep 19, 2024
ARS Annual report to shareholders Aug 15, 2024 Mar 31, 2024
DEFA14A Additional proxy material Aug 15, 2024 —
DEF 14A Proxy statement Aug 15, 2024 Sep 27, 2024
10-K/A Amended annual report Aug 15, 2024 Mar 31, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2024 Aug 14, 2024
8-K Current report
Other events
Aug 12, 2024 Aug 12, 2024
8-K Current report
Auditor change
Jul 3, 2024 Jul 1, 2024
10-K Annual report Jun 27, 2024 Mar 31, 2024
8-K Current report
Results of operations
Jun 27, 2024 Jun 27, 2024
8-K Current report
Other events
May 24, 2024 May 24, 2024
8-K Current report
Other events
May 17, 2024 May 15, 2024
EFFECT Filing May 16, 2024 —
424B4 Prospectus May 16, 2024 —
EFFECT Filing May 15, 2024 —
POS AM Amendment no 1 May 15, 2024 —
S-1/A Amended registration statement May 13, 2024 —
CORRESP Letter to the SEC May 10, 2024 —
CORRESP Letter to the SEC May 10, 2024 —
8-K Current report
Other events
May 10, 2024 May 10, 2024
S-1/A Amended registration statement Apr 25, 2024 —
8-K Current report
Other events
Apr 25, 2024 Apr 25, 2024
S-1/A Amended registration statement Apr 5, 2024 —
UPLOAD Letter from the SEC Mar 28, 2024 —
S-1 Registration statement Mar 22, 2024 —
10-Q Quarterly report Feb 14, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 14, 2024 Feb 14, 2024
8-K/A Amended current report
Officer or director change
Dec 22, 2023 Nov 7, 2023
8-K Current report
Officer or director change
Nov 27, 2023 Nov 19, 2023
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 14, 2023 Nov 14, 2023
8-K Current report
Officer or director change
Nov 13, 2023 Nov 7, 2023
8-K Current report
Other events
Oct 4, 2023 Oct 4, 2023
8-K Current report
Shareholder vote results
Sep 18, 2023 Sep 15, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
ARS Annual report to shareholders Jul 27, 2023 Mar 31, 2023
DEF 14A Proxy statement Jul 27, 2023 Sep 15, 2023
PRE 14A Preliminary proxy statement Jul 17, 2023 Sep 15, 2023
8-K Current report
Officer or director change
Jul 6, 2023 Jul 3, 2023
10-K Annual report Jun 28, 2023 Mar 31, 2023
8-K Current report
Results of operations
Jun 28, 2023 Jun 28, 2023
8-K Current report
Other events
Apr 25, 2023 Apr 25, 2023
10-Q Quarterly report Feb 13, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 13, 2023 Feb 13, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Listing notice
Oct 27, 2022 Oct 25, 2022
8-K Current report
Other events
Sep 29, 2022 Sep 29, 2022
424B5 Prospectus supplement Sep 29, 2022 —
8-K Current report
Other events
Sep 29, 2022 Sep 29, 2022
S-8 Employee stock plan registration Sep 19, 2022 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
Sep 19, 2022 Sep 15, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
424B5 Prospectus supplement Aug 3, 2022 —
DEF 14A Proxy statement Jul 27, 2022 Jul 27, 2022
PRE 14A Preliminary proxy statement Jul 15, 2022 Jul 14, 2022
10-K Annual report Jun 28, 2022 Mar 31, 2022
8-K Current report
Results of operations
Jun 28, 2022 Jun 28, 2022
8-K Current report
Officer or director change
Mar 28, 2022 Mar 23, 2022
8-K Current report
Material agreement
Mar 24, 2022 Mar 24, 2022
424B5 Prospectus supplement Mar 24, 2022 —
10-Q Quarterly report Feb 14, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 14, 2022 Feb 14, 2022
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 9, 2021 Nov 9, 2021
8-K Current report
Material agreement
Nov 1, 2021 Oct 27, 2021
EFFECT Filing Oct 21, 2021 —
S-3 Shelf registration Sep 30, 2021 —
8-K Current report
Shareholder vote results
Sep 17, 2021 Sep 15, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
DEFA14A Additional proxy material Jul 28, 2021 —
DEF 14A Proxy statement Jul 28, 2021 Sep 15, 2021
8-K Current report
Officer or director change
Jul 1, 2021 Jun 28, 2021
10-K Annual report Jun 24, 2021 Mar 31, 2021
8-K Current report
Results of operations
Jun 24, 2021 Jun 24, 2021
8-K Current report
Other events
Jun 11, 2021 Jun 10, 2021
424B5 Prospectus supplement Jun 11, 2021 —
8-K Current report
Material agreement
Mar 22, 2021 Mar 22, 2021
424B5 Prospectus supplement Mar 22, 2021 —
10-Q Quarterly report Feb 10, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 10, 2021 Feb 10, 2021
8-K Current report
Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
8-K Current report
Material agreement
Dec 10, 2020 Dec 7, 2020
8-K Current report
Auditor change, Officer or director change, Other events
Nov 3, 2020 Oct 30, 2020
10-Q Quarterly report Oct 28, 2020 Sep 30, 2020
8-K Current report
Results of operations
Oct 28, 2020 Oct 28, 2020
S-8 Employee stock plan registration Sep 15, 2020 —
8-K Current report
Officer or director change, Shareholder vote results
Sep 15, 2020 Sep 15, 2020
10-Q Quarterly report Aug 11, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 11, 2020 Aug 11, 2020
DEFA14A Additional proxy material Jul 28, 2020 —
DEF 14A Proxy statement Jul 28, 2020 Sep 15, 2020
10-K Annual report Jun 25, 2020 Mar 31, 2020
8-K Current report
Results of operations
Jun 25, 2020 Jun 25, 2020
EFFECT Filing Mar 30, 2020 —
424B5 Prospectus supplement Mar 30, 2020 —
CORRESP Letter to the SEC Mar 26, 2020 —
UPLOAD Letter from the SEC Mar 26, 2020 —
8-K Current report
Officer or director change
Mar 23, 2020 Mar 17, 2020
S-3 Shelf registration Mar 19, 2020 —
8-K Current report
Officer or director change
Feb 21, 2020 Feb 14, 2020
10-Q Quarterly report Feb 10, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 10, 2020 Feb 6, 2020
D Filing Jan 24, 2020 —
8-K Current report
Unregistered share sale
Jan 22, 2020 Jan 22, 2020
8-K Current report
Material agreement, Other events
Jan 17, 2020 Jan 17, 2020
424B5 Prospectus supplement Jan 17, 2020 —
8-K Current report
Other events
Dec 19, 2019 Dec 13, 2019
424B4 Prospectus Dec 16, 2019 —
EFFECT Filing Dec 12, 2019 —
CORRESP Letter to the SEC Dec 11, 2019 —
CORRESP Letter to the SEC Dec 11, 2019 —
S-1/A Amended registration statement Dec 11, 2019 —
FWP Free writing prospectus Dec 2, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
AEMD (Nasdaq)
Fiscal year ends
March 31
Incorporated in
NV
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
882291
Former names
BISHOP EQUITIES INC (until Mar 13, 2000)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.